Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating MIR-200a in human oesophageal squamous cell carcinoma cells

Bioscience Reports

Volumn 35, Issue 5, 2015, Pages

  Liu, Mei ^a   Hu, Chenfei ^a   Xu, Qing ^a   Chen, Lechuang ^a   Ma, Kai ^a   Xu, Ningzhi ^a   Zhu, Hongxia ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Kelch like ECH Associated protein 1 (Keap1); Krupple like factor 4 (KLF4); Methylseleninic acid (MSA); Micro ribonucleic acid 200a (MIR 200a); Nuclear factor E2 related factor 2 (Nrf2); Oesophageal squamous cell carcinoma (ESCC).

Indexed keywords

ANTAGOMIR; ANTINEOPLASTIC AGENT; KELCH LIKE ECH ASSOCIATED PROTEIN 1; KRUPPEL LIKE FACTOR 4; METHYLSELENINIC ACID; MICRORNA 200A; SELENIUM DERIVATIVE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; KEAP1 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; METHYLSELENIC ACID; MICRORNA; MIRN200 MICRORNA, HUMAN; NFE2L2 PROTEIN, HUMAN; ORGANOSELENIUM DERIVATIVE; SIGNAL PEPTIDE;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA CELL; UPREGULATION; ACTIVE TRANSPORT; CARCINOMA, SQUAMOUS CELL; DRUG EFFECTS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICRORNAS; NF-E2-RELATED FACTOR 2; ORGANOSELENIUM COMPOUNDS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84947438886     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20150092     Document Type: Article

References (30)

1. Duffield-Lillico, A.J., Reid, M.E., Turnbull, B.W., Combs, Jr, G.F., Slate, E.H., Fischbach, L.A., Marshall, J.R. and Clark, L.C. (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev. 11, 630-639
2. Li, G.X., Lee, H.J., Wang, Z., Hu, H., Liao, J.D., Watts, J.C., Combs, Jr., G.F. and Lu, J. (2008) Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29, 1005-1012
3. Wang, L., Bonorden, M.J., Li, G.X., Lee, H.J., Hu, H., Zhang, Y., Liao, J.D., Cleary, M.P. and Lu, J. (2009) Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev. Res. 2, 484-495
4. Mark, S.D., Qiao, Y.L., Dawsey, S.M., Wu, Y.P., Katki, H., Gunter, E.W., Fraumeni, Jr., J.F., Blot, W.J., Dong, Z.W. and Taylor, P.R. (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J. Natl. Cancer Inst. 92, 1753-1763
5. Limburg, P.J., Wei, W., Ahnen, D.J., Qiao, Y., Hawk, E.T., Wang, G., Giffen, C.A., Roth, M.J., Lu, N., Korn, E.L. et al. (2005) Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 129, 863-873
6. Chun, K.S., Kundu, J., Kundu, J.K. and Surh, Y.J. (2014) Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals. Toxicol. Lett. 229, 73-84
7. Yang, Y., Cai, X., Yang, J., Sun, X., Hu, C., Yan, Z., Xu, X., Lu, W., Wang, X. and Cao, P. (2014) Chemoprevention of dietary digitoflavone on colitis-Associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation. Mol. Cancer 13, 48
8. Jaramillo, M.C. and Zhang, D.D. (2013) The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 27, 2179-2191
9. Zhang, D.D. (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38, 769-789
10. Venugopal, R. and Jaiswal, A.K. (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. U.S.A. 93, 14960-14965
11. Zhang, D.D., Lo, S.C., Cross, J.V., Templeton, D.J. and Hannink, M. (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24, 10941-10953
12. Ohkoshi, A., Suzuki, T., Ono, M., Kobayashi, T. and Yamamoto, M. (2013) Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis. Cancer Prev. Res. 6, 149-159
13. Terazawa, R., Garud, D.R., Hamada, N., Fujita, Y., Itoh, T., Nozawa, Y., Nakane, K., Deguchi, T., Koketsu, M. and Ito, M. (2010) Identification of organoselenium compounds that possess chemopreventive properties in human prostate cancer LNCaP cells. Bioorg. Med. Chem. 18, 7001-7008
14. Singh, C.K., Ndiaye, M.A., Siddiqui, I.A., Nihal, M., Havighurst, T., Kim, K., Zhong, W., Mukhtar, H. and Ahmad, N. (2014) Methaneseleninic acid and gamma-Tocopherol combination inhibits prostate tumor growth in vivo in a xenograft mouse model. Oncotarget 5, 3651-3661
15. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
16. Eades, G., Yang, M., Yao, Y., Zhang, Y. and Zhou, Q. (2011) miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J. Biol. Chem. 286, 40725-40733
17. van Jaarsveld, M.T., Helleman, J., Boersma, A.W., van Kuijk, P.F., van Ijcken, W.F., Despierre, E., Vergote, I., Mathijssen, R.H., Berns, E.M., Verweij, J. et al. (2013) miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 32, 4284-4293
18. Wei, J., Zhang, Y., Luo, Y., Wang, Z., Bi, S., Song, D., Dai, Y., Wang, T., Qiu, L., Wen, L. et al. (2014) Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfbeta1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. Free Radic. Biol. Med. 67, 91-102
19. Hu, C., Liu, M., Zhang, W., Xu, Q., Ma, K., Chen, L., Wang, Z., He, S., Zhu, H. and Xu, N. (2014) Upregulation of KLF4 by methylseleninic acid in human esophageal squamous cell carcinoma cells: modification of histone H3 acetylation through HAT/HDAC interplay. Mol. Carcinog. 54, 1051-1059
20. Chen, C., Ridzon, D.A., Broomer, A.J., Zhou, Z., Lee, D.H., Nguyen, J.T., Barbisin, M., Xu, N.L., Mahuvakar, V.R. and Andersen, M.R. (2005) Real-Time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179
21. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25, 402-408
22. Zhou, C., Liu, S., Zhou, X., Xue, L., Quan, L., Lu, N., Zhang, G., Bai, J., Wang, Y., Liu, Z. et al. (2005) Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma. Int. J. Cancer 113, 891-898
23. Ke, L. (2002) Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa. Int. J. Cancer 102, 271-274
24. Engel, L.S., Chow, W.H., Vaughan, T.L., Gammon, M.D., Risch, H.A., Stanford, J.L., Schoenberg, J.B., Mayne, S.T., Dubrow, R., Rotterdam, H. et al. (2003) Population attributable risks of esophageal and gastric cancers. J. Natl. Cancer Inst. 95, 1404-1413
25. Mena, S., Ortega, A and Estrela, J.M. (2009) Oxidative stress in environmental-induced carcinogenesis. Mutat. Res. 674, 36-44
26. Kwak, M.K. and Kensler, T.W. (2010) Targeting NRF2 signaling for cancer chemoprevention. Toxicol. Appl. Pharmacol. 244, 66-76
27. Klaunig, J.E., Kamendulis, L.M and Hocevar, B.A. (2010) Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol. 38, 96-109
28. Wang, B., Zhu, X., Kim, Y., Li, J., Huang, S., Saleem, S., Li, R.C., Xu, Y., Dore, S. and Cao, W. (2012) Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic. Biol. Med. 52, 928-936
29. Liu, S., Zhang, H., Zhu, L., Zhao, L. and Dong, Y. (2008) Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition. Mol. Cancer Res. 6, 306-313
30. Yuan, J.H., Yang, F., Chen, B.F., Lu, Z., Huo, X.S., Zhou, W.P., Wang, F. and Sun, S.H. (2011) The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. Hepatology 54, 2025-2035